BroPair Spiromax Evrópusambandið - íslenska - EMA (European Medicines Agency)

bropair spiromax

teva b.v. - salmeterol xinafoate, flútikasón nef - astma - lyf til veikindi öndunarvegi sjúkdómum, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Seffalair Spiromax Evrópusambandið - íslenska - EMA (European Medicines Agency)

seffalair spiromax

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Gavreto Evrópusambandið - íslenska - EMA (European Medicines Agency)

gavreto

roche registration gmbh  - pralsetinib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.

Esomeprazol Actavis Magasýruþolin tafla 40 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

esomeprazol actavis magasýruþolin tafla 40 mg

actavis group ptc ehf. - esomeprazolum magnesíum - magasýruþolin tafla - 40 mg

Esomeprazol Actavis Magasýruþolin tafla 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

esomeprazol actavis magasýruþolin tafla 20 mg

actavis group ptc ehf. - esomeprazolum magnesíum - magasýruþolin tafla - 20 mg

Esomeprazol Krka Magasýruþolið hart hylki 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

esomeprazol krka magasýruþolið hart hylki 20 mg

krka sverige ab - esomeprazolum magnesíum díhýdrat - magasýruþolið hart hylki - 20 mg